Clarifications to the NIH and AHRQ Policy for Application Submission

Dear Colleagues:

In mid-April we forwarded NOT-OD-14-074  re: a NIH and AHRQ  change in policy on application submissions.  The below notification (NOT-OD-14-082) provides clarification on this policy change.  Please read, and redistribute broadly to relevant faculty and researchers in your area.

Thank you!

Greg Ruth
Communications Manager
Office of Research

NOT-OD-14-082Clarifications to the NIH and AHRQ Policy for Application Submission

The National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ) announce clarifications to policy on application submissions that was updated recently (NOT-OD-14-074 – NIH and AHRQ Announce Updated Policy for Application Submission).


Due Dates – Questions were received that asked whether a new (A0) application, following an unsuccessful resubmission (A1) application, could be submitted only for the next, appropriate due date. To clarify, following an unsuccessful resubmission (A1) application and release of the summary statement, an applicant may submit the same idea as a new (A0) application for any due date in the future that is appropriate for the grant mechanism and Funding Opportunity Announcement (FOA).

Applicability – Questions were received asking which grant programs fall under the policy. To clarify, the updated policy applies to major types of applications and activity codes – including applications for research grants, the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, Career Development Awards, Individual Fellowships, Institutional Training Grants, Resource Grants, Program Projects, and Center Grants. However, eligibility criteria and any other restrictions or requirements in the FOA prevail.

Options –Subsequent questions asked whether a time limit exists between an unsuccessful resubmission (A1) application and the subsequent new (A0) application, whether the number of such cycles is limited, and whether an intervening resubmission (A1) application is required in order to submit a new (A0) application again. The updated policy has no time limit between an unsuccessful resubmission (A1) application and a subsequent, new (A0) application, or between an unsuccessful new (A0) application and a subsequent new (A0) application. The time limit of thirty-seven months between an unsuccessful (A0) application and the subsequent resubmission (A1) application does remain in effect. The number of submission cycles is not limited, but NIH encourages applicants to update their applications to reflect the status of the field over the interim period. The updated policy does not preclude submission of a new (A0) application following an unsuccessful new (A0) application, without an intervening resubmission (A1) application.

Thank you,

Jeff Warner

Research Policy Analyst
Research Policy Analysis and Coordination
University of California, Office of the President

Scroll to Top